Bacteria in gut 'play role in irritable bowel syndrome'

   May 27, 6:42 pm

Washington, May 27 (ANI): A new study has definitively linked an overgrowth of bacteria in the gut to the Irritable Bowel Syndrome (IBS).

This is the first study to use this "gold standard" method of connecting bacteria to the cause of the disease that affects an estimated number of 30 million people in the United States.

Earlier studies have indicated that bacteria play a role in the disease, including breath tests detecting methane - a byproduct of bacterial fermentation in the gut. This study was the first to make the link using bacterial cultures.

Cedars-Sinai physician examined samples of patients' small bowel cultures to confirm the presence of small intestinal bacterial overgrowth - or SIBO - in more than 320 subjects.

In patients with IBS, more than a third were also diagnosed with small intestine bacterial overgrowth, in comparison to fewer than 10 percent of those without the disorder.

Out of those with diarrhea-predominant IBS, 60 percent also had bacterial overgrowth.

"While we found compelling evidence in the past that bacterial overgrowth is a contributing cause of IBS, making this link through bacterial cultures is the gold standard of diagnosis," said Mark Pimentel, MD, director of the Cedars-Sinai GI Motility Program and an author of the study.

"This clear evidence of the role bacteria play in the disease underscores our clinical trial findings, which show that antibiotics are a successful treatment for IBS," he said.

Patients with IBS suffer symptoms that can include painful bloating, constipation, diarrhea or an alternating pattern of both.

Many of these patients try to avoid social interactions because they are embarrassed by their symptoms.

Pimentel has led clinical trials that have shown Rifaximin, a targeted antibiotic absorbed only in the gut, is an effective treatment for patients with IBS.

"In the past, treatments for IBS have always focused on trying to alleviate the symptoms," said Pimentel, who first bucked standard medical thought more than a decade ago when he suggested bacteria played a major role in the disease.

"Patients who take Rifaximin experience relief of their symptoms even after they stop taking the medication. This new study confirms what our findings with the antibiotic and our previous studies always led us to believe: Bacteria are key contributors to the cause of IBS ," he said.

This study has been published in Digestive Diseases and Sciences. (ANI)

2 min of intense exercise helps elderly stay healthy Jul 28, 11:54 am
London, July 28 (ANI): Experts have revealed that intense workout regime for only 2 minutes twice a week over a month and a half would help people aged over 60 stay fit and lowered their chance of suffering a heart attack or stroke.
Full Story
Brain activity influencing protein may help treat obesity, diabetes Jul 27, 3:20 pm
Washington, July 27 (ANI): A new study has found that a particular protein that controls gene and has a crucial role in certain brain areas to regulate metabolism, and could help in treatment of obesity and diabetes.
Full Story
Revolutionize yet simple blood test may help detect all cancers Jul 27, 2:41 pm
London, July 27 (ANI): Scientists have developed a new universal and easy test that might help in detecting all the cancers in the near future.
Full Story
Diabetic patients should have low carb diets: Study Jul 27, 1:58 pm
Washington, July 27 (ANI): A new study has revealed that diet with low carbohydrates is good for Type 1 and Type 2 diabetes patients.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY